$IRTC News

iRhythm: The Algorithmic Margin Inflection Changes The Story

2 Reasons to Like IRTC (and 1 Not So Much)

Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168

The Top 5 Analyst Questions From iRhythm’s Q2 Earnings Call

iRhythm (IRTC) Q2 2026 Earnings Call Transcript

Why iRhythm (IRTC) Stock Is Trading Up Today

iRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says

Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168

IRhythm grows heart monitoring leadership with $288M VitalConnect buy

IRTC Q2 Deep Dive: Product Portfolio Expansion and Margin Gains Highlight Quarter

Why iRhythm Holdings (IRTC) Is Up 9.1% After Raising 2026 Outlook and Advancing Legal Settlement – And What's Next

The Doctor Will See You Now…Everywhere

iRhythm advances cardiac monitoring provision with $287.5m VitalConnect acquisition

iRhythm Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation

iRhythm Technologies, Inc. Q2 2026 Earnings Call Summary

iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care

Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168

Needham Maintains Buy on iRhythm Holdings, Lowers Price Target to $192

Evercore ISI Group Maintains Outperform on iRhythm Holdings, Raises Price Target to $165

iRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript